---
title: Improve walking through Amazonian dance
nct_id: NCT06967493
phase: NA
status: RECRUITING
sponsor: Federal University of Rio Grande do Sul
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06967493"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06967493"
last_fetched: "2026-05-10T14:03:22.972Z"
source: "Parkinson's Pathways (curated)"
---
# Improve walking through Amazonian dance

**Goal (in five words):** Improve walking through Amazonian dance

**Official Title:** "Amazonian Dance for Parkinson": a Protocol Study for a Randomized Clinical Trial on Motor and Non-motor Symptoms of People With Parkinson's.

**Trial ID:** [NCT06967493](https://clinicaltrials.gov/study/NCT06967493)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Federal University of Rio Grande do Sul
- **Target Enrollment:** 80 participants
- **Start Date:** 2025-08-04
- **Completion Date:** 2025-11-26
- **Conditions:** Parkinson Disease
- **Interventions:** Amazonian Dance, Nordic Walking
- **Intervention Types:** BEHAVIORAL

## Summary For Families

Goal: to see if a guided Amazonian Dance program can improve walking, balance, mood and thinking in people with mild to moderate Parkinson's, compared with a structured aerobic option. Approach: participants are randomized to Amazonian Dance, which uses music, rhythmic stepping, coordinated limb patterns and cognitive challenges to retrain timing, balance and gait, or to Nordic walking, which uses poles to boost posture and aerobic fitness; both are offered as add-on physical therapies alongside regular anti-Parkinson medications and do not replace levodopa or other drugs. Eligibility: adults 50 to 80 years old with Parkinson's at Hoehn and Yahr stages I to III who have been on anti-Parkinson drugs for at least a year and can follow instructions; people with recent surgery, DBS, pacemakers, other neurologic or serious chronic diseases, or lower-limb prostheses are excluded.

## Eligibility

- **Minimum age:** 50 Years
- **Maximum age:** 80 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Confirmed diagnosis of PD according to the London Brain Bank Criteria;
* Able to understand the verbal instructions for the tests;
* Hoehn and Yahr (H\&Y) stages I-III
* ≥ 1 year undergoing medical treatment for PD with regular use of anti-parkinsonian drugs
* Capability to participate will be based on the Unified Parkinson's Disease Rating Scale -motor examination

Exclusion Criteria:

* Recent surgeries,
* Deep brain stimulation (DBS);
* Other associated neurological diseases or chronic diseases
* Fitted with a pacemaker;
* Prostheses in the lower limbs;
```

## Locations (2)

- Universidade Federal do Pará, Castanhal, Pennsylvania, Brazil _(-1.2939, -47.9264)_
  - Elren Passos Monteiro — (CONTACT) — +55 (91) 98480-1027 — elren.monteiro@ufpa.br
- Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil _(-30.0328, -51.2302)_
  - Aline Nogueira Haas, PhD — (CONTACT) — +55 (51) 99963-3496 — alinehaas2@hotmail.com

## Central Contacts

- Aline Nogueira Haas, PhD — (CONTACT) — +5551999633496 — alinehaas02@hotmail.com

---

*Canonical: https://parkinsonspathways.com/trial/NCT06967493*  
*HTML version: https://parkinsonspathways.com/trial/NCT06967493*  
*Source data: https://clinicaltrials.gov/study/NCT06967493*